Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Healthcare Market 

5.1. COVID-19 Landscape: Animal Healthcare Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Healthcare Market, By Animal Type

8.1. Animal Healthcare Market, by Animal Type, 2023-2032

8.1.1. Production Animal

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Companion Animal

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Animal Healthcare Market, By Product Type

9.1. Animal Healthcare Market, by Product Type, 2023-2032

9.1.1. Vaccines

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Pharmaceuticals

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Feed Additives

9.1.3.1. Market Revenue and Forecast (2020-2032)

9.1.4. Diagnostics

9.1.4.1. Market Revenue and Forecast (2020-2032)

9.1.5. Equipment and Disposables

9.1.5.1. Market Revenue and Forecast (2020-2032)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Animal Healthcare Market, By Distribution Channel

10.1. Animal Healthcare Market, by Distribution Channel Type, 2023-2032

10.1.1. Retail Pharmacy

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. E-commerce

10.1.2.1. Market Revenue and Forecast (2020-2032)

10.1.3. Hospital Pharmacy

10.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Animal Healthcare Market, By End Use

11.1. Animal Healthcare Market, by End Use Type, 2023-2032

11.1.1. Reference Laboratories

11.1.1.1. Market Revenue and Forecast (2020-2032)

11.1.2. Point of care testing/ in-house testing

11.1.2.1. Market Revenue and Forecast (2020-2032)

11.1.3. Veterinary Hospitals & Clinics

11.1.3.1. Market Revenue and Forecast (2020-2032)

11.1.4. Others

11.1.4.1. Market Revenue and Forecast (2020-2032)

Chapter 12. Global Animal Healthcare Market, By Treatments Type

12.1. Animal Healthcare Market, by Treatments, 2023-2032

12.1.1. Allergies

12.1.1.1. Market Revenue and Forecast (2020-2032)

12.1.2. Arthritis

12.1.2.1. Market Revenue and Forecast (2020-2032)

12.1.3. Gastrointestinal Disease

12.1.3.1. Market Revenue and Forecast (2020-2032)

12.1.4. Difficult Dermatology Cases

12.1.4.1. Market Revenue and Forecast (2020-2032)

12.1.5. Others

12.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 13. Global Animal Healthcare  Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Animal (2020-2032)

13.1.2. Market Revenue and Forecast, by Product (2020-2032)

13.1.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.1.4. Market Revenue and Forecast, by End Use (2020-2032)

13.1.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Animal (2020-2032)

13.1.6.2. Market Revenue and Forecast, by Product (2020-2032)

13.1.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.1.6.4. Market Revenue and Forecast, by End Use (2020-2032)

13.1.7. Market Revenue and Forecast, by Treatments (2020-2032) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Animal (2020-2032)

13.1.8.2. Market Revenue and Forecast, by Product (2020-2032)

13.1.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.1.8.4. Market Revenue and Forecast, by End Use (2020-2032)

13.1.8.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Animal (2020-2032)

13.2.2. Market Revenue and Forecast, by Product (2020-2032)

13.2.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.4. Market Revenue and Forecast, by End Use (2020-2032) 

13.2.5. Market Revenue and Forecast, by Treatments (2020-2032) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Animal (2020-2032)

13.2.6.2. Market Revenue and Forecast, by Product (2020-2032)

13.2.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.7. Market Revenue and Forecast, by End Use (2020-2032) 

13.2.8. Market Revenue and Forecast, by Treatments (2020-2032) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Animal (2020-2032)

13.2.9.2. Market Revenue and Forecast, by Product (2020-2032)

13.2.9.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.10. Market Revenue and Forecast, by End Use (2020-2032)

13.2.11. Market Revenue and Forecast, by Treatments (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Animal (2020-2032)

13.2.12.2. Market Revenue and Forecast, by Product (2020-2032)

13.2.12.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.12.4. Market Revenue and Forecast, by End Use (2020-2032)

13.2.13. Market Revenue and Forecast, by Treatments (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Animal (2020-2032)

13.2.14.2. Market Revenue and Forecast, by Product (2020-2032)

13.2.14.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.2.14.4. Market Revenue and Forecast, by End Use (2020-2032)

13.2.15. Market Revenue and Forecast, by Treatments (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Animal (2020-2032)

13.3.2. Market Revenue and Forecast, by Product (2020-2032)

13.3.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.4. Market Revenue and Forecast, by End Use (2020-2032)

13.3.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Animal (2020-2032)

13.3.6.2. Market Revenue and Forecast, by Product (2020-2032)

13.3.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.6.4. Market Revenue and Forecast, by End Use (2020-2032)

13.3.7. Market Revenue and Forecast, by Treatments (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Animal (2020-2032)

13.3.8.2. Market Revenue and Forecast, by Product (2020-2032)

13.3.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.8.4. Market Revenue and Forecast, by End Use (2020-2032)

13.3.9. Market Revenue and Forecast, by Treatments (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Animal (2020-2032)

13.3.10.2. Market Revenue and Forecast, by Product (2020-2032)

13.3.10.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.10.4. Market Revenue and Forecast, by End Use (2020-2032)

13.3.10.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Animal (2020-2032)

13.3.11.2. Market Revenue and Forecast, by Product (2020-2032)

13.3.11.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.3.11.4. Market Revenue and Forecast, by End Use (2020-2032)

13.3.11.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Animal (2020-2032)

13.4.2. Market Revenue and Forecast, by Product (2020-2032)

13.4.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.4. Market Revenue and Forecast, by End Use (2020-2032)

13.4.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Animal (2020-2032)

13.4.6.2. Market Revenue and Forecast, by Product (2020-2032)

13.4.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.6.4. Market Revenue and Forecast, by End Use (2020-2032)

13.4.7. Market Revenue and Forecast, by Treatments (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Animal (2020-2032)

13.4.8.2. Market Revenue and Forecast, by Product (2020-2032)

13.4.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.8.4. Market Revenue and Forecast, by End Use (2020-2032)

13.4.9. Market Revenue and Forecast, by Treatments (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Animal (2020-2032)

13.4.10.2. Market Revenue and Forecast, by Product (2020-2032)

13.4.10.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.10.4. Market Revenue and Forecast, by End Use (2020-2032)

13.4.10.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Animal (2020-2032)

13.4.11.2. Market Revenue and Forecast, by Product (2020-2032)

13.4.11.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.4.11.4. Market Revenue and Forecast, by End Use (2020-2032)

13.4.11.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Animal (2020-2032)

13.5.2. Market Revenue and Forecast, by Product (2020-2032)

13.5.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.5.4. Market Revenue and Forecast, by End Use (2020-2032)

13.5.5. Market Revenue and Forecast, by Treatments (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Animal (2020-2032)

13.5.6.2. Market Revenue and Forecast, by Product (2020-2032)

13.5.6.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.5.6.4. Market Revenue and Forecast, by End Use (2020-2032)

13.5.7. Market Revenue and Forecast, by Treatments (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Animal (2020-2032)

13.5.8.2. Market Revenue and Forecast, by Product (2020-2032)

13.5.8.3. Market Revenue and Forecast, by Distribution Channel (2020-2032)

13.5.8.4. Market Revenue and Forecast, by End Use (2020-2032)

13.5.8.5. Market Revenue and Forecast, by Treatments (2020-2032)

Chapter 14. Company Profiles

14.1. Elanco

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Bayer

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Dechra Pharmaceuticals

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Neogen

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Boehringer Ingelheim

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Merck & Co, Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Zoetis

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Nutreco N.V.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Virbac

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Vetquinol S.A.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms